Federica Mazzuca

Rome, 00189, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

Diagnostic challenge of occult ER-positive breast carcinoma within bone marrow indolent B-cell lymphoma and response to CDK4/6 inhibitor: a case report.

Diagnostic challenge of occult ER-positive breast carcinoma within bone marrow indolent B-cell lymphoma and response to CDK4/6 inhibitor: a case report.

Journal: Journal of medical case reports
Published: March 26, 2026

On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.

On-Treatment Grade 3-4 Neutropenia and Clinical Outcomes with Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: ReTrITA Real-World Evidence.

Journal: Oncology research
Published: February 19, 2026

The role of the molecular tumor board: learnings from the ROME trial.

The role of the molecular tumor board: learnings from the ROME trial.

Journal: NPJ precision oncology
Published: November 18, 2025

Can TP53, TMB and TME Expand the Immunotherapy Benefit in Metastatic Colorectal Cancer?

Can TP53, TMB and TME Expand the Immunotherapy Benefit in Metastatic Colorectal Cancer?

Journal: Cancers
Published: October 28, 2025

Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.

Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.

Journal: Cancers
Published: October 02, 2025

Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging Treatments.

Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging Treatments.

Journal: Cancers
Published: September 20, 2025

The role of germline mutations in non-small cell lung cancer: A systematic review of emerging genetic drivers and clinical implications.

The role of germline mutations in non-small cell lung cancer: A systematic review of emerging genetic drivers and clinical implications.

Journal: Critical reviews in oncology/hematology
Published: August 19, 2025

Sexual Dysfunction in Female Rectal and Anal Cancer Survivors: Pathophysiology, Clinical Management, and Integration into Survivorship Care.

Sexual Dysfunction in Female Rectal and Anal Cancer Survivors: Pathophysiology, Clinical Management, and Integration into Survivorship Care.

Journal: Cancers
Published: August 12, 2025

Relationship between single-nucleotide polymorphisms and cancer immunotherapy efficacy and toxicity: a systematic review.

Relationship between single-nucleotide polymorphisms and cancer immunotherapy efficacy and toxicity: a systematic review.

Journal: Frontiers in oncology
Published: June 25, 2025

Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study.

Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study.

Journal: Cancers
Published: May 24, 2025

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 04, 2025

The financial toll of cancer: uncovering the links between financial toxicity and symptom burden.

The financial toll of cancer: uncovering the links between financial toxicity and symptom burden.

Journal: The oncologist
Published: February 03, 2025
Showing 1-12 of 78

Last Updated: 09/26/2026